Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Revenue

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹8,749 Cr₹7,782 Cr₹621 Cr₹58,719 Cr₹4,980 Cr

What is the latest Revenue of MANKIND PHARMA ?

The latest Revenue ratio of MANKIND PHARMA is ₹8,749 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹8,749 Cr
Mar2023₹7,782 Cr
Mar2022₹621 Cr
Mar2021₹58,719 Cr
Mar2020₹4,980 Cr

How is Revenue of MANKIND PHARMA Trending?

Years Revenue % Change
Mar2024 ₹8,749 Cr
12.44
Mar2023 ₹7,782 Cr
1,152.18
Mar2022 ₹621 Cr
-98.94
Mar2021 ₹58,719 Cr
1,079.10
Mar2020 ₹4,980 Cr -

Compare Revenue of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,303.1 Cr 1.1% -7% 9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.1%

-7%

9.7%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses